The variety of med-spas, weight-loss clinics, and concierge practices the place sufferers pay a membership payment for direct, typically same-day entry to physicians, has exploded in recent times. However whereas sufferers pay for these providers out-of-pocket, suppliers nonetheless typically depend on software program constructed for conventional, insurance-based care.
VITL, an 18-month-old startup, claims to be fixing one of many sector’s greatest tech bottlenecks by constructing an e-prescribing platform — a digital instrument for sending and managing prescriptions — tailor-made for cash-pay medical companies.
On Wednesday, VITL introduced a $7.5 million Collection A funding spherical led by SignalFire.
Founder and CEO Charlie Jordan constructed the Nashville-based firm after realizing simply how a lot time medical suppliers spend managing prescriptions for therapies not lined by insurance coverage.
Many suppliers nonetheless depend on faxes or cellphone calls to ship prescriptions to compounding pharmacies, which create customized drugs to order, typically with out understanding the ultimate price to the affected person or how lengthy the order will take to fill. VITL’s platform fixes this by connecting clinics to a nationwide community of compounding pharmacies, providing real-time value comparisons and Amazon-style order monitoring.
“We shorten the prescription time from a number of minutes down to a couple seconds,” Jordan informed TechCrunch.
For clinics that put in dozens of orders every day, that point financial savings provides up.
Techcrunch occasion
San Francisco, CA
|
October 13-15, 2026
VITL estimates that its know-how saves purchasers as much as two full workdays per 30 days by automating an in any other case cumbersome and opaque course of.
Money-pay suppliers are clearly seeing the worth in VITL’s platform. Slightly over a yr after its launch, the corporate stories onboarding greater than 630 clinics and producing eight figures in annualized recurring income (ARR), which means the corporate is on tempo to usher in at the least $10 million per yr.
That stated, 630 prospects represents only a fraction of a market that features tens of 1000’s of clinics throughout the U.S. As curiosity in GLP-1s –the category of medicine that features Ozempic and Wegovy — peptides, and aesthetic procedures like Botox grows extra mainstream, the variety of cash-pay healthcare companies is just set to develop.
VITL by no means pitched SignalFire, however the startup’s speedy progress caught its consideration. That curiosity translated into a brand new, $7.5 million Collection A led by the enterprise agency, which is thought for utilizing knowledge and AI to determine breakout corporations.
VITL competes partly with Surescripts, the trade’s e-prescribing pioneer, and with boutique clinic platforms like Jane Software program, which bundle prescription options into their broader digital well being document (EHR) software program. What units VITL aside from these opponents, it says, is its singular concentrate on the workflow necessities of the cash-pay medical sector.
